World's top Pharmaceuticals stocks
Manufacturers and marketers of generic and specialty drugs, as well as researchers and developers of new drugs, medical products and procedures.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
LLYEli Lilly and Co | $877.92bn | 71.71 | 0.53% |
NOVO BNovo Nordisk A/S | DKK4.06tn | 43.54 | 1.08% |
JNJJohnson & Johnson | $398.45bn | 19.15 | 2.91% |
JNJ WDJohnson & Johnson | $397.54bn | 20.6 | 2.81% |
ABBVAbbvie | $343.04bn | 38.56 | 3.12% |
MRKMerck & Co | $293.68bn | 13.87 | 2.62% |
ROGRoche Holding AG | CH₣209.56bn | 14.32 | 3.65% |
RORoche Holding AG | CH₣209.56bn | 15.44 | 3.39% |
AZNAstraZeneca | £184.92bn | 37.42 | 1.9% |
NOVNNovartis AG | CH₣199.30bn | 19.09 | 3.38% |
AMGNAmgen | $178.64bn | 60.03 | 2.63% |
PFEPfizer | $165.86bn | 10.78 | 5.67% |
SANSanofi SA | €129.36bn | 19.54 | 3.64% |
GILDGilead Sciences | $103.10bn | 11.87 | 3.67% |
CELG RTBristol-Myers Squibb Co | $99.61bn | 0.01 | 7800% |
BMYBristol-Myers Squibb Co | $99.61bn | 13.14 | 4.76% |
CSLCSL | AU$143.38bn | 36.52 | 1.33% |
GSKGSK | £67.71bn | 11.52 | 3.67% |
ZTSZoetis | $86.57bn | 34.49 | 0.84% |
MRKMerck KGaA | €73.13bn | 23.43 | 1.31% |